Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Real-Time Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
RTNominal unchange10.060 0.000 (0.000%)

12/12/2019 10:40

HEC Pharm (01558) to cooperate with Alibaba Health (00241)

[ET Net News Agency, 12 December 2019] YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
(01558) said the company entered into a strategic cooperation framework agreement with
Alibaba Health Technology (China) Limited (Alibaba Health (China)).
The company will cooperate with Alibaba Health (China) to carry out influenza special
projects, including assisting the company in optimizing the supply chain management and
enhancing the patient education services by code scanning through the drug tracking
systems in the Ma Shang Fang Xin platform of Alibaba Health (China); promoting influenza
prevention and control knowledge to the public and exploring the brand building of HEC
acknowledged by internet users through the ecosystem of Alibaba Health (China). The term
of cooperation shall be one year.
Alibaba Health (China) is a company whose principal activities include provision of
pharmaceutical e-commerce, medical big data and artificial intelligence, internet
healthcare services, consumer healthcare platform and health management and other
businesses in the PRC. It is an indirect wholly-owned subsidiary of Alibaba Health
Information Technology Limited (00241). (RC)

Remark: Real time quote last updated: 17/01/2020 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2020 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.